Clinical trial
Atomoxetine in the Treatment of Binge Eating Disorder
NCT00327834 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00327834 |
|---|---|
| Title | Atomoxetine in the Treatment of Binge Eating Disorder |
| Official title | Atomoxetine in the Treatment of Binge Eating Disorder: A Single-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study in Outpatients |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | University of Cincinnati |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Binge-eating Disorder |
| Intervention type | Drug |
| Interventions | atomoxetine |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | May 19, 2006 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: